This Week in Virology (TWiV) recently featured Dr. Sabra Klein, from the Johns Hopkins Bloomberg School of Public Health, part of the Johns Hopkins Center of Excellence for Influenza Research and Surveillance (JHCEIRS). Her research aims to understand how males and females differ in their immune response to viral infection. In Episode 624, she discusses… Read more »
In a recent report published in Science, CEIRS investigators were part of a group of researchers in the Netherlands that investigated similarities and differences in pathogenesis of COVID-19, MERS, and SARS in cynomolgus macaques (Rockx 2020). Prior to this study, little information on the pathogenesis of SARS-CoV-2 infection was available. Investigators were aiming to characterize the pathogenesis of SARS-CoV-2 infection and compare findings to the pathogenesis of MERS-CoV and SARS-CoV.
Last week, the FDA issued their authorization for emergency use of a SARS-CoV-2 antibody test developed by Dr. Florian Krammer’s microbiology lab for in vitro diagnosis of COVID-19 cases. Dr. Krammer, an investigator at CEIRS Center for Research on Influenza Pathogenesis (CRIP), started developing the test in January 2020. The ELISA test detects the presence… Read more »
Dr. David Topham, Principal Investigator at the New York Influenza Center of Excellence (NYICE), was interviewed by NBC’s TODAY as part of an article on the process of coronavirus antibody testing. Antibody tests can be used to determine if a person had a past coronavirus infection. TODAY notes that while more than 150 antibody tests… Read more »
The Bloomberg Daybreak Radio Show covers a range of business, economic, and market news between local and global levels. Now on Wednesday and Friday mornings, listeners can tune in for scientific discussion as well. Dr. Andrew Pekosz, co-Principal Investigator of the JHCEIRS Center and a Professor of Molecular Microbiology and Immunology at the Johns Hopkins… Read more »
Over the past several years, the CEIRS Center directors and members of the CEIRS Pandemic Response Planning Committee (PRAC) have worked to develop the CEIRS Influenza Response Plan, in coordination with CEIRS NIAID leadership. The plan details a strategic approach for a CEIRS response to an influenza pandemic or novel influenza virus with pandemic potential… Read more »
Dr. Florian Krammer, a Professor at the Icahn School of Medicine at Mount Sinai and part of the Center for Research on Influenza Pathogenesis (CRIP), talks about efforts to develop one of the first antibody-based tests for SARS-CoV-2 infections. Some patients may exhibit few, if any, symptoms of COVID-19, proving these tests to be important to determine whether people have been infected with COVID-19.
Dr. Ben Cowling and Way Wen Lim, from The University of Hong Kong, part of SJCEIRS, co-authored an opinion piece about ongoing efforts and effective control measures for limiting the COVID-19 outbreak.
Lauren Sauer and Dr. Andrew Pekosz, researchers from Johns Hopkins University and JHCEIRS, speak as part of a panel of experts on infectious disease and public health. Their panel discussion was recorded at a U.S. House of Representatives office building in Washington, DC.
Investigators Peter Thielen and Tom Mehoke, from Johns Hopkins University Applied Physics Laboratory, part of the JHCEIRS Center, discuss their efforts toward sequencing the SARS-CoV-2 virus from clinical samples. Their use of the MinION handheld sequencers and protocol optimization advances will allow them to deploy these units at point-of-care settings to deliver same-day sequencing results.